Pain Management and Surgical Devices Global Market

–Forecast to 2025

Pain Management and Surgical Devices Global Market estimated to be worth

$8,824.7 million by 2025

IQ4I Research & Consultancy published a new report on “Pain Management and
Surgical Devices Global Market – Forecast To 2025” This report analyzes and studies the
overall market, major Drivers & Opportunities, Restraints & Threats in North America,
Europe, Asia-Pacific and Rest of the World.

IQ4I’s Report Contains 127 market data tables and 96 figures spread through 385
pages and an exhaustive TOC on “Pain Management and Surgical Devices Global
Market”, [Pain Management and Surgical Devices {Pain Devices (Internal Devices (Spinal
Cord Stimulator, Peripheral Nerve Stimulator, Others), External Devices (TENS, NMES,
Others), Pain Surgeries (Kyphoplasty and Vertebroplasty, Fixation Devices, Artificial Discs,
Ablation (Radiofrequency Ablation, Cryoablation}; Treatment Type {Invasive, Non
invasive}; Application {Neuropathic pain, Cancer pain, FBSS, MSD, Others}; End-Users
{Hospitals, Ambulatory surgery centers, Pain Management centers and Others}; Region
{North America, Europe, Asia-Pacific and Rest of the World}]

According to International Association for the Study of Pain (IASP), pain is an unpleasant
sensory and emotional experience associated with actual or potential tissue damage. Pain is
classified as acute and chronic pain depending on how long the pain lasts. Acute pain
occurs suddenly due to disease, injury, or inflammation and disappears when the cause of
pain is no longer exists. Some of the causes of acute pain are trauma, surgery, broken
bones, burns and cuts. Chronic pain is a persistent pain that usually lasts longer than six
months. Some of the chronic pain conditions are migraine, cancer pain, neuropathic pain,
musculoskeletal pain and arthritis pain. Pain is not always completely curable, but can be
treated with pain management devices and surgery. The pain management devices such as
spinal cord stimulators, peripheral nerve stimulators, TENS and NMES uses low electricity to
block pain signals passing from nerve to brain and minimize the pain. Surgical procedures
such as kyphoplasty, vertebroplasty and implant devices like spacers, screws and artificial
discs are used to treat back pain caused by degenerative disc disease. The ablation
procedures such as radiofrequency ablation and cryoablation are used to treat chronic pain
and cancer pain by damaging pain causing nerve tissue.

According to IQ4I Analysis, pain management and surgical device global market is expected
to grow at a high single digit CAGR to reach $8,824.7 million by 2025. Increase in the
prevalence of chronic diseases and pain disorders, rise in aging population, and adverse
effects of opioids, are driving the market. Availability of reimbursement, stringent regulations
to limit the opioids use and technological advancements are some of the opportunities of the
market. However, contraindications and complication with the implantations of

IQ4I Research & Consultancy Pvt. Ltd. Page 1

Pain Management and Surgical Devices Global Market

–Forecast to 2025

neuromodulation devices, the high cost of devices are some of the restraints of the market.
Stringent regulatory requirements for the product approval and availability of alternate
products are some of the threats to the pain management and surgical device market.

Pain management and surgical devices market is classified based on product, application,
end-user and region. The Product’s market is classified into pain devices and pain surgeries,
wherein the pain devices segment accounted for the largest share in 2018 and is projected
to grow at a high single digit CAGR from 2018 to 2025. Pain devices are further classified
into internal pain devices and external pain devices. Among these internal pain devices
accounted for the largest share in 2018 and projected to grow at a high single digit CAGR
from 2018 to 2025.

Pain management and surgical devices global market based on application is divided into
neuropathic pain, cancer pain, Failed back surgery syndrome, musculoskeletal disorders
and others. Musculoskeletal disorders segment accounted for the largest share in 2018 and
is expected to grow at a high single digit CAGR from 2018 to 2025, due to increase in the
prevalence of musculoskeletal disorders.

The pain management and surgical devices global market based on End - user is divided
into Hospitals, ambulatory surgery centers, pain management centers and others. Hospitals
accounted the largest share in 2018 and expected to grow at a high single digit CAGR from
2018 to 2025. Availability of skilled persons and availability of technically advanced devices
led the market growth in this segment.

The pain management and surgical devices global market based on geography is divided
into North America, Europe, Asia-Pacific and Rest of the world. North America region
commanded the largest share in 2018 and is expected to grow at a mid single digit CAGR. A
high prevalence of chronic conditions such as back pain, orthopaedic pain, cancer pain,
migraine and growth in aging population and adverse effects of opioids led the market
growth in this region. However, Asia-Pacific is expected to grow at a high single digit CAGR
from 2018 to 2025 owing to the rapidly increasing aging population with high prevalence of
chronic conditions, improving healthcare infrastructure and rise in healthcare spending in the
emerging countries, such as India and China.

Technological advancements like wireless technology in neuromodulation, Miniaturization,

and convergence technologies will drive the market. The new products such as Dorsal root
ganglion stimulator, deep brain stimulator and peripheral nerve stimulator are FDA approved

IQ4I Research & Consultancy Pvt. Ltd. Page 2

Pain Management and Surgical Devices Global Market

–Forecast to 2025

products, which are used to treat various chronic pain conditions. The Winner EVO, an
external pain device and is an example for technological convergence, which combines
Electro therapy, Cold laser therapy, ultrasound therapy and Light therapy, developed by
Rich-Mar, Inc. (U.S.).

The pain management and surgical device market is consolidated with top five players
occupying major share of the market. The top players in the market are Medtronic PLC.
(Ireland), Abbott Laboratories (U.S.), Boston scientific corporation (U.S.), Johnson and
Johnson (U.S.) and Nevrocorp (U.S.) which control the major share of the market, as these
companies focus on strong distribution network, patents, acquisitions, approvals and product
launches. For instance, in July 2018, J&J (DePuy synthes), launched its product Concord Lift
expandable interbody device in U.S. The device is designed for the treatment of patients
with degenerative disk disease.

The companies in this segment are coming up with new technological advancements to
maintain their leadership status in pain management and surgical devices market. Intellis
implantable neurostimulator is a world’s smallest implantable devices developed by
Medtronic PLC. (Ireland). Abbott Laboratory (U.S.) is the only company which providing
dorsal root ganglion system to treat chronic pain.

Major players in Pain management and surgical Device market include Abbott Laboratories
(U.S.), Boston Scientific corporation (U.S.), Medtronic, Plc. (Ireland), Nevrocorp (U.S.),
Nuvectra (U.S.), Stryker corporation (U.S.), Avanos medicals (Halyard health Inc.) (U.S.),
Johnson and Johnson (DePuy Synthes) (U.S.), Merit medicals system (U.S.), Inc., DJO
Finance Ltd. (Chattanooga) (U.S.).

Some of the other companies operating in Pain management and Surgical Device market
are BMK global medical (U.S), Globus medical (U.S.), Biomedical research Ltd (Ireland),
Cefaly technologies (U.S.), ElectroCore Medical LLC (U.S.), Electromedical products
international, Inc, (U.S.), eNeura, Inc. (U.S.), Iskara medicals d.o.o (Solvenia), Stimwave
LLc. (U.S.), Zynex medicals (U.S.), Zetroz systems, LLc. (U.S.), GymnaUniphy NV.
(Belgium), Evomed (Australia), Neuros medicals, Inc. (U.S.), Johari Digital Healthcare Ltd
(India), Zealmax Innovations Pvt. Ltd. (India), Bioness (U.S.), Mainstay Medical International
PLC (Ireland), SPR Therapeutics (U.S.), Stimwave, LLC. (U.S.), Neuroimpulse (Italy).

IQ4I Research & Consultancy Pvt. Ltd. Page 3

Pain Management and Surgical Devices Global Market

–Forecast to 2025

Reasons for buying this report:

 Pain Management and Surgical devices global market is expected to reach $8,824.7
million by 2025 at a CAGR of 6.9%.
 Identification and analysis of the Pain Management and Surgical devices market by
identifying various segments by product (site, product type), treatment type,
application, end-user and geography.
 Revenue forecast of Pain Management and Surgical devices market and strategic
analysis of each sub-segment with respect to segmental growth trends.
 Identification of major market trends, Porter's model, and factors driving and
restraining Pain Management and Surgical devices market growth.
 Market penetration analysis of Pain Management and Surgical devices and analysis
of Pain Management and Surgical devices global market by number of units and their
average selling prices.
 Revenue forecast of the Pain Management and Surgical devices market with respect
to North America (U.S. and Rest of NA), Europe (Germany, France, U.K and Rest of
Europe), Asia-Pacific (Japan, China, India and Rest of APAC) and Rest of the World
(Brazil, Rest of Latin America and Middle-East & Others) regions.
 Analysis of the opportunities for stakeholders by identifying the high-growth
segments of the market.
 Identification of key technology developments and innovations driving the market.
 Analysis of the market share, patent and supply chain of the Pain Management and
Surgical devices market by major players.
 Individual market share of Spinal cord devices, Radiofrequency ablation, Kyphoplasty
and Vertebroplasty devices.
 Profiles of major players in Pain Management and Surgical devices market and
analysis of their product offerings, financial revenue, business strategies, SWOTs
and market shares.

IQ4I Research & Consultancy Pvt. Ltd. Page 4

Pain Management and Surgical Devices Global Market

–Forecast to 2025

FIGURE 1

PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET

SEGMENTATION

Pain Management And Surgical Devices

Global Market

Treatment
Product Application End-User Region
Type
Pain Pain Neuro-
Invasive Hospitals NA EU APAC RoW
devices surgery pathic Pain

Internal External Kypho- Non Cancer

ASC U.S. Germany Japan Brazil
device device plasty Invasive Pain
Fixation PMC & Rest of
FBSS Rest of NA France China
SCS TENS devices Others LATAM

ADR MSD ME &

PNS NMES U.K. India
Others

Ablation Other Pain Rest of Rest of

Others Others Europe APAC
RF
Ablation

Cryo-
ablation

Source: American Pain Society (APS), American Academy of Pain Medicine (AAPM), Academy of Integrated Pain
Management (AIPM), European Pain Federation (EPF), British Pain Society (BPS), Australian Pain Management
and Association (APMA), Pain Clinic Society of Japan (PCSP), World Health Organization (WHO), Center for
Disease Control and Prevention (CDC), Industrial Experts and IQ4I Analysis.

IQ4I Research & Consultancy Pvt. Ltd. Page 5